Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Therapeutic Prospects of mRNA-Based Gene Therapy for Glioblastoma.

Tang X, Zhang S, Fu R, Zhang L, Huang K, Peng H, Dai L, Chen Q.

Front Oncol. 2019 Nov 8;9:1208. doi: 10.3389/fonc.2019.01208. eCollection 2019. Review.

2.

Rapid identification and validation of novel targeted approaches for Glioblastoma: A combined ex vivo-in vivo pharmaco-omic model.

Daher A, de Groot J.

Exp Neurol. 2018 Jan;299(Pt B):281-288. doi: 10.1016/j.expneurol.2017.09.006. Epub 2017 Sep 18. Review.

PMID:
28923369
3.

Biological gene delivery vehicles: beyond viral vectors.

Seow Y, Wood MJ.

Mol Ther. 2009 May;17(5):767-77. doi: 10.1038/mt.2009.41. Epub 2009 Mar 10. Review.

4.

A Critical Overview of Targeted Therapies for Glioblastoma.

Jain KK.

Front Oncol. 2018 Oct 15;8:419. doi: 10.3389/fonc.2018.00419. eCollection 2018. Review.

5.

Human NT2 neural precursor-derived tumor-infiltrating cells as delivery vehicles for treatment of glioblastoma.

Zhao Y, Wang S.

Hum Gene Ther. 2010 Jun;21(6):683-94. doi: 10.1089/hum.2009.196.

PMID:
20113165
6.

Theranostic Nanoparticles for RNA-Based Cancer Treatment.

Revia RA, Stephen ZR, Zhang M.

Acc Chem Res. 2019 Jun 18;52(6):1496-1506. doi: 10.1021/acs.accounts.9b00101. Epub 2019 May 28.

PMID:
31135134
7.

Macromolecular Drug Carriers for Targeted Glioblastoma Therapy: Preclinical Studies, Challenges, and Future Perspectives.

Raucher D, Dragojevic S, Ryu J.

Front Oncol. 2018 Dec 17;8:624. doi: 10.3389/fonc.2018.00624. eCollection 2018. Review.

8.

Aptamer for imaging and therapeutic targeting of brain tumor glioblastoma.

Delač M, Motaln H, Ulrich H, Lah TT.

Cytometry A. 2015 Sep;87(9):806-16. doi: 10.1002/cyto.a.22715. Epub 2015 Jul 17. Review.

9.

The application of mRNA-based gene transfer in mesenchymal stem cell-mediated cytotoxicity of glioma cells.

Guo XR, Yang ZS, Tang XJ, Zou DD, Gui H, Wang XL, Ma SN, Yuan YH, Fang J, Wang B, Zhang L, Sun XY, Warnock GL, Dai LJ, Tu HJ.

Oncotarget. 2016 Aug 23;7(34):55529-55542. doi: 10.18632/oncotarget.10835.

10.

Nanomedicine associated with photodynamic therapy for glioblastoma treatment.

de Paula LB, Primo FL, Tedesco AC.

Biophys Rev. 2017 Oct;9(5):761-773. doi: 10.1007/s12551-017-0293-3. Epub 2017 Aug 19. Review.

11.

Targeting intercellular adhesion molecule-1 prolongs survival in mice bearing bevacizumab-resistant glioblastoma.

Piao Y, Henry V, Tiao N, Park SY, Martinez-Ledesma J, Dong JW, Balasubramaniyan V, de Groot JF.

Oncotarget. 2017 Jun 29;8(57):96970-96983. doi: 10.18632/oncotarget.18859. eCollection 2017 Nov 14.

12.

Destination Brain: the Past, Present, and Future of Therapeutic Gene Delivery.

Joshi CR, Labhasetwar V, Ghorpade A.

J Neuroimmune Pharmacol. 2017 Mar;12(1):51-83. doi: 10.1007/s11481-016-9724-3. Epub 2017 Feb 3. Review.

13.

Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).

Foffi G, Pastore A, Piazza F, Temussi PA.

Phys Biol. 2013 Aug;10(4):040301. Epub 2013 Aug 2.

PMID:
23912807
14.

Breaching barriers in glioblastoma. Part II: Targeted drug delivery and lipid nanoparticles.

Miranda A, Blanco-Prieto MJ, Sousa J, Pais A, Vitorino C.

Int J Pharm. 2017 Oct 5;531(1):389-410. doi: 10.1016/j.ijpharm.2017.07.049. Epub 2017 Aug 9. Review.

PMID:
28801108
15.

Astrocyte-elevated gene-1 (AEG-1): Glioblastoma's helping hand during times of hypoxia and glucose deprivation?

Baumann BC, Dorsey JF.

Cancer Biol Ther. 2011 Jan 1;11(1):40-2. Epub 2011 Jan 1. No abstract available.

PMID:
21150314
16.

Molecular imaging of biological gene delivery vehicles for targeted cancer therapy: beyond viral vectors.

Min JJ, Nguyen VH, Gambhir SS.

Nucl Med Mol Imaging. 2010 Apr;44(1):15-24. doi: 10.1007/s13139-009-0006-3. Epub 2010 Feb 26.

17.

Toward Personalized Targeted Therapeutics: An Overview.

Weathers SS, Gilbert MR.

Neurotherapeutics. 2017 Apr;14(2):256-264. doi: 10.1007/s13311-016-0496-5. Review.

18.

RNA interference for glioblastoma therapy: Innovation ladder from the bench to clinical trials.

Lozada-Delgado EL, Grafals-Ruiz N, Vivas-Mejía PE.

Life Sci. 2017 Nov 1;188:26-36. doi: 10.1016/j.lfs.2017.08.027. Epub 2017 Aug 31. Review.

19.

Combination therapy to checkmate Glioblastoma: clinical challenges and advances.

Ghosh D, Nandi S, Bhattacharjee S.

Clin Transl Med. 2018 Oct 16;7(1):33. doi: 10.1186/s40169-018-0211-8. Review.

20.

A New Approach in Gene Therapy of Glioblastoma Multiforme: Human Olfactory Ensheathing Cells as a Novel Carrier for Suicide Gene Delivery.

Hashemi M, Fallah A, Aghayan HR, Arjmand B, Yazdani N, Verdi J, Ghodsi SM, Miri SM, Hadjighassem M.

Mol Neurobiol. 2016 Oct;53(8):5118-28. doi: 10.1007/s12035-015-9412-y. Epub 2015 Sep 22.

PMID:
26395282

Supplemental Content

Support Center